tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Jinxin Fertility Group Reports Significant Financial Losses in H1 2025

Story Highlights
Jinxin Fertility Group Reports Significant Financial Losses in H1 2025

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Jinxin Fertility Group Ltd. ( (HK:1951) ) has shared an announcement.

Jinxin Fertility Group Ltd. reported a significant financial downturn for the first half of 2025, with a revenue decrease of 10.7% and a net loss of approximately RMB1,044.1 million, compared to a net profit in the same period of 2024. The company also experienced a substantial decline in non-IFRS adjusted net profit and EBITDA, reflecting challenges in maintaining its financial performance. The board decided against declaring an interim dividend, signaling a cautious approach amid the financial setbacks.

The most recent analyst rating on (HK:1951) stock is a Buy with a HK$4.00 price target. To see the full list of analyst forecasts on Jinxin Fertility Group Ltd. stock, see the HK:1951 Stock Forecast page.

More about Jinxin Fertility Group Ltd.

Jinxin Fertility Group Ltd. is a company incorporated under the laws of the Cayman Islands, operating in the fertility industry. The company focuses on providing fertility services and related healthcare solutions.

Average Trading Volume: 86,206,993

Technical Sentiment Signal: Buy

Current Market Cap: HK$8.84B

See more insights into 1951 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1